4.6 Article

Emerging Role of miR-21-5p in Neuron-Glia Dysregulation and Exosome Transfer Using Multiple Models of Alzheimer's Disease

Related references

Note: Only part of the references are listed.
Review Medicine, Research & Experimental

MicroRNAs in Alzheimer's disease: Potential diagnostic markers and therapeutic targets

Sen Liu et al.

Summary: Alzheimer's disease is a common neurodegenerative disease affecting millions worldwide. Recent studies have shown differential abundance and varieties of miRNAs in central and peripheral tissues of AD patients.

BIOMEDICINE & PHARMACOTHERAPY (2022)

Article Radiology, Nuclear Medicine & Medical Imaging

Clozapine induces astrocyte-dependent FDG-PET hypometabolism

Andreia Rocha et al.

Summary: This study used FDG-PET imaging to investigate the impact of the antipsychotic drug clozapine on brain glucose metabolism in rats, and found that downregulation of GLT-1 resulted in astrocyte-dependent cortical hypometabolism, resembling the hypometabolic signature observed in people developing dementia.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2022)

Review Neurosciences

MicroRNA-21 Is a Versatile Regulator and Potential Treatment Target in Central Nervous System Disorders

Xue Bai et al.

Summary: MiR-21 has emerged as a versatile regulator in central nervous system disorders, particularly in the regulation of apoptosis and inflammation. Understanding the mechanisms of miR-21 in CNS disorders could lead to its potential as a therapeutic target.

FRONTIERS IN MOLECULAR NEUROSCIENCE (2022)

Article Multidisciplinary Sciences

Somatic genomic changes in single Alzheimer's disease neurons

Michael B. Miller et al.

Summary: This study analyzed single-cell whole-genome sequencing data from the prefrontal cortex and hippocampus of individuals with Alzheimer's disease, revealing an increase in somatic DNA alterations. These alterations, driven by distinct processes and nucleotide changes, potentially implicate nucleotide oxidation. The accumulation of DNA alterations in Alzheimer's disease may lead to genomic damage to neurons and impair their function.

NATURE (2022)

Article Pharmacology & Pharmacy

Protective Signature of IFNγ-Stimulated Microglia Relies on miR-124-3p Regulation From the Secretome Released by Mutant APP Swedish Neuronal Cells

Goncalo Garcia et al.

Summary: The study reveals that miR-124 plays a significant role in the inflammation and pathophysiology of Alzheimer's disease. The modulation of miR-124 in neuroblastoma cells affects the polarization of microglia subtypes in the context of inflammation. Furthermore, the study demonstrates the transfer of miR-124 from neurons to microglia, highlighting the importance of neuronal survival in the underlying mechanisms of inflammation in Alzheimer's disease.

FRONTIERS IN PHARMACOLOGY (2022)

Review Neurosciences

Advances in the development of new biomarkers for Alzheimer's disease

Timofey O. Klyucherev et al.

Summary: Alzheimer's disease is a complex and progressive neurodegenerative dementia. With the aging population, the prevalence of AD is expected to increase, posing greater burden on healthcare systems. There is a need for new diagnostic tests that can detect AD at an early stage with high specificity and low cost. Recent developments in blood, plasma, and ocular biomarkers show promising potential for the diagnosis of AD.

TRANSLATIONAL NEURODEGENERATION (2022)

Article Cell Biology

Neurotoxic Astrocytes Directly Converted from Sporadic and Familial ALS Patient Fibroblasts Reveal Signature Diversities and miR-146a Theragnostic Potential in Specific Subtypes

Catia Gomes et al.

Summary: Transdifferentiation of fibroblasts from ALS patients into astrocytes can help study the pathophysiology of the disease. Modulating miR-146a can restore neuroprotective phenotype and improve neuronal function in ALS patients.

CELLS (2022)

Review Health Care Sciences & Services

Dysregulated miRNAs as Biomarkers and Therapeutical Targets in Neurodegenerative Diseases

Giulia Gentile et al.

Summary: Alzheimer's disease (AD), Parkinson's disease (PD), and Amyotrophic Lateral Sclerosis (ALS) are representative neurodegenerative diseases (NDs) characterized by selective neuron degeneration, with a lack of effective biomarkers and therapies. MicroRNAs (miRNAs) have shown promise in diagnostics and therapy of these NDs due to their abnormal expression and ability to target multiple molecules and pathways.

JOURNAL OF PERSONALIZED MEDICINE (2022)

Review Immunology

Astrocytic and microglial cells as the modulators of neuroinflammation in Alzheimer's disease

Deepali Singh

Summary: Neuroinflammation is caused by the misfiring of immune cells in the central nervous system and can have both positive and negative effects on neurodevelopment and post-injury tissue. Chronic or uncontrolled inflammatory responses may lead to neurodegenerative diseases, while abnormal activation of glial cells can mediate neuroinflammation.

JOURNAL OF NEUROINFLAMMATION (2022)

Article Biochemistry & Molecular Biology

Human Primary Astrocytes Differently Respond to Pro- and Anti-Inflammatory Stimuli

Piotr Szpakowski et al.

Summary: Astrocytes, once considered passive brain cells, have been found to play a more active role in the central nervous system. This study aimed to evaluate the production of inflammatory chemokines and neurotrophic factors by primary human astrocytes after inflammatory or anti-inflammatory stimulation. The results showed that only astrocytes induced by inflammatory mediators produced certain chemokines, and pro-inflammatory conditions decreased the release of a neurotrophic factor while anti-inflammatory cytokines increased its production.

BIOMEDICINES (2022)

Review Neurosciences

The SH-SY5Y human neuroblastoma cell line, a relevant in vitro cell model for investigating neurotoxicology in human: Focus on organic pollutants

Lorena Lopez-Suarez et al.

Summary: Investigating the toxicity of chemicals on the human brain traditionally relies on animal and cell models, which have limitations due to species differences, ethical concerns, and time/cost constraints. Human cell models, such as the SH-SY5Y cell line, offer a relevant alternative for studying neurotoxicity and prioritizing in vivo testing. This review examines the characteristics and use of the SH-SY5Y cell line for studying the effects of organic environmental pollutants on neurotoxicity, highlighting the impacts on cellular processes and neurotransmitter homeostasis.

NEUROTOXICOLOGY (2022)

Article Cell Biology

Suppression of Hepatic PPARα in Primary Biliary Cholangitis Is Modulated by miR-155

Monika Adamowicz et al.

Summary: The expression of PPARα is reduced in the liver of patients with primary biliary cholangitis (PBC), likely due to overexpression of miR-155. Ursodeoxycholic acid (UDCA) effectively reduces the expression of miR-155, preventing the suppression of PPARα.

CELLS (2022)

Article Biochemistry & Molecular Biology

Intrathecal Injection of the Secretome from ALS Motor Neurons Regulated for miR-124 Expression Prevents Disease Outcomes in SOD1-G93A Mice

Marta Barbosa et al.

Summary: The intrathecal administration of the secretome from anti-miR-124-treated mSOD1 MNs is a potential therapeutic strategy for halting/delaying disease progression in an ALS mouse model. It prevents motor impairment, muscle atrophy, glial reactivity/dysfunction, and neurodegeneration, while regulating gene expression and inflammatory miRNAs.

BIOMEDICINES (2022)

Review Clinical Neurology

Alzheimer's disease drug development pipeline: 2022

Jeffrey Cummings et al.

Summary: Alzheimer's disease is a global health crisis, and there are numerous clinical trials and drugs in development to treat and improve the symptoms and progression of the disease. The pipeline of drug development includes a diverse array of treatments, including disease-modifying therapies, cognitive enhancing treatments, and drugs for neuropsychiatric symptoms. Advances in drug design, outcome measures, biomarker use, and trial conduct show promise in accelerating the delivery of new and improved treatments for Alzheimer's disease patients.

ALZHEIMERS & DEMENTIA-TRANSLATIONAL RESEARCH & CLINICAL INTERVENTIONS (2022)

Article Biology

Resolving cell state in iPSC-derived human neural samples with multiplexed fluorescence imaging

Martin L. Tomov et al.

Summary: The study utilizes PRISM technology for multiplexed imaging analysis of iPSC-derived neural cultures to understand neural cell differentiation and disease models. The method is amenable to automation and scalability to multiple protein targets and samples.

COMMUNICATIONS BIOLOGY (2021)

Article Biochemistry & Molecular Biology

Inhibition of miR-21 Promotes Cellular Senescence in NT2-Derived Astrocytes

Vanda Balint et al.

Summary: Astrocytes are key cells in the CNS that can be regulated by miRNAs to affect cellular functions, including senescence. Studies suggest that miR-21 may be a potential regulator of astrocyte senescence.

BIOCHEMISTRY-MOSCOW (2021)

Article Cell Biology

MicroRNA 21 Elicits a Pro-inflammatory Response in Macrophages, with Exosomes Functioning as Delivery Vehicles

Radha Madhyastha et al.

Summary: The study elucidates the role of miR-21 in regulating macrophage inflammatory responses, showing that miR-21 overexpression significantly upregulates pro-inflammatory cytokines and affects macrophage phenotype development. Additionally, exosomal miR-21 can also convey pro-inflammatory effects to naive macrophages.

INFLAMMATION (2021)

Review Clinical Neurology

Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here?

Fangda Leng et al.

Summary: Microglial activation and neuroinflammation play important roles in Alzheimer's disease, affecting disease progression and pathologies. Current research focuses on the interplay between neuroinflammation and amyloid and tau pathologies, with a specific interest in modulating microglia as a therapeutic strategy for AD.

NATURE REVIEWS NEUROLOGY (2021)

Article Immunology

Arginase 1 Insufficiency Precipitates Amyloid-β Deposition and Hastens Behavioral Impairment in a Mouse Model of Amyloidosis

Chao Ma et al.

Summary: Arginase plays a crucial role in Alzheimer's disease, and its deficiency in myeloid cells may exacerbate amyloid-beta deposition, behavioral impairments, and autophagy. Proper function of Arginase and arginine metabolism in myeloid cells is essential in restricting amyloidosis.

FRONTIERS IN IMMUNOLOGY (2021)

Article Neurosciences

The promise of microRNA-based therapies in Alzheimer's disease: challenges and perspectives

Hannah Walgrave et al.

Summary: Researchers review the regulation of microRNAs in the pathophysiology of Alzheimer's disease and critically discuss the potential for developing microRNA-based therapeutics using these insights.

MOLECULAR NEURODEGENERATION (2021)

Article Biochemistry & Molecular Biology

Activation of PPARα enhances astroglial uptake and degradation of β-amyloid

Sumita Raha et al.

Summary: The combination of low-dose gemfibrozil and retinoic acid enhances the uptake and degradation of amyloid (A beta) in astrocytes through a PPAR alpha-dependent pathway, potentially offering a new therapeutic approach for Alzheimer's disease.

SCIENCE SIGNALING (2021)

Article Geriatrics & Gerontology

Circulating Inflamma-miRs as Potential Biomarkers of Cognitive Impairment in Patients Affected by Alzheimer's Disease

Angelica Giuliani et al.

Summary: In AD patients, the expression levels of miRNAs involved in regulating the inflammatory process were significantly increased, with miR-21-5p and miR-126-3p showing a strong inverse relationship with cognitive impairment. MiR-126-3p was able to effectively discriminate between different levels of cognitive impairment in AD patients.

FRONTIERS IN AGING NEUROSCIENCE (2021)

Review Neurosciences

Inflamma-MicroRNAs in Alzheimer's Disease: From Disease Pathogenesis to Therapeutic Potentials

Yuanyuan Liang et al.

Summary: Alzheimer's disease is the most common cause of senile dementia. Recent studies have shown that neuroinflammation is involved in the pathogenesis of Alzheimer's disease, and miRNA may play an important role in regulating neuroinflammation processes, potentially serving as potential diagnostic biomarkers and therapeutic targets.

FRONTIERS IN CELLULAR NEUROSCIENCE (2021)

Article Immunology

Alzheimer's Risk Gene TREM2 Determines Functional Properties of New Type of Human iPSC-Derived Microglia

Marvin Reich et al.

Summary: Researchers have successfully generated microglia-like cells from human induced pluripotent stem cells for studying AD-related disease settings and performing compound screening and testing for drug discovery. The cells exhibit upregulation of TREM2 mRNA levels, a risk gene for AD, and show functional differences in calcium response and migration compared to TREM2-deficient cells. This opens up new possibilities for AD research and drug development.

FRONTIERS IN IMMUNOLOGY (2021)

Review Cell Biology

Astrocytes in Alzheimer's Disease: Pathological Significance and Molecular Pathways

Pranav Preman et al.

Summary: Astrocytes are essential for normal nervous system operation and play active roles in neurodegenerative disorders like Alzheimer's. Recent data shows that different astrocyte states are linked to specific stages of Alzheimer's disease, with transcriptomics technologies aiding in characterizing these pathological states.

CELLS (2021)

Review Oncology

miR-21: a non-specific biomarker of all maladies

Ana E. Jenike et al.

Summary: miRNA-21 is considered as a specific predictive or prognostic biomarker for at least 29 diseases, but lacks specificity for any one disease, thus making it not an ideal candidate for a biomarker despite continued evaluation. This issue of non-specificity in biomarker designation is shared with other common, ubiquitous miRNAs and warrants concern for their use as biomarkers as well.

BIOMARKER RESEARCH (2021)

Article Cell Biology

Recovery of Depleted miR-146a in ALS Cortical Astrocytes Reverts Cell Aberrancies and Prevents Paracrine Pathogenicity on Microglia and Motor Neurons

Marta Barbosa et al.

Summary: This study investigated the role of miR-146a in ALS astrocytes and found that upregulating miR-146a can alleviate the detrimental effects of astrocytes on neurons and microglia, suggesting miR-146a as a potential therapeutic target for ALS.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)

Article Biochemistry & Molecular Biology

Overexpression of miR-124 in Motor Neurons Plays a Key Role in ALS Pathological Processes

Ana Rita Vaz et al.

Summary: miR-124 is an important regulator of neurogenesis, with its dysregulation associated with neurodegeneration. Targeting miR-124 levels can prevent dysfunction in neuronal network, mitochondria dynamics, axonal transport, and synaptic signaling. Additionally, miR-124 may play a role in activating spinal microglia through paracrine signaling, contributing to ALS pathology.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Biochemistry & Molecular Biology

Microglial activation and tau propagate jointly across Braak stages

Tharick A. Pascoal et al.

Summary: The study found a correlation between microglial activation and tau accumulation in patients with Alzheimer's disease, following a Braak-like pattern. The co-occurrence of A β, tau, and microglial abnormalities was identified as the strongest predictor of cognitive impairment in the study population.

NATURE MEDICINE (2021)

Article Cell Biology

Tau oligomer induced HMGB1 release contributes to cellular senescence and neuropathology linked to Alzheimer's disease and frontotemporal dementia

Sagar Gaikwad et al.

Summary: The study demonstrates that TauO-induced neuroinflammation is primarily mediated through HMGB1 release and inflammatory SASP, leading to astrocyte senescence. Inhibition of HMGB1 release can prevent TauO-induced cellular senescence, reduce neuroinflammation, and improve cognitive function.

CELL REPORTS (2021)

Article Cell Biology

Neuronal Dynamics and miRNA Signaling Differ between SH-SY5Y APPSwe and PSEN1 Mutant iPSC-Derived AD Models upon Modulation with miR-124 Mimic and Inhibitor

Goncalo Garcia et al.

Summary: Neuronal miRNA dysregulation may play a role in Alzheimer's disease pathophysiology, with miR-124 being a critical player in neuronal function. The role of miR-124 may vary depending on the neuronal AD model, but strict control of miR-124 levels is crucial for proper neuronal function. The iNEU-PSEN cellular model shows promise for AD mechanistic studies and personalized therapeutic strategies.

CELLS (2021)

Article Medicine, Research & Experimental

Regulation of PPARα by APP in Alzheimer disease affects the pharmacological modulation of synaptic activity

Francisco Saez-Orellana et al.

Summary: This study found a possible correlation between lipid metabolism and the onset of Alzheimer's disease. Activation of PPAR alpha showed improvement in synaptic plasticity in AD cases and was inversely related to APP expression. The association was reversed in the case of APP silencing, indicating the key role of PPAR alpha in synaptic activity control.

JCI INSIGHT (2021)

Article Medicine, Research & Experimental

MicroRNA-146a switches microglial phenotypes to resist the pathological processes and cognitive degradation of Alzheimer's disease

Chunmei Liang et al.

Summary: Alzheimer's disease has no effective treatment, with research focused on Aβ and Tau. Abnormal microglial polarization is a key feature in the progression of AD, affecting neuroprotective functions. MiR-146a shows promise in opposing AD by switching microglial phenotypes and reducing neuroinflammation.

THERANOSTICS (2021)

Review Biochemistry & Molecular Biology

Modeling Alzheimer's disease with iPSC-derived brain cells

Jay Penney et al.

MOLECULAR PSYCHIATRY (2020)

Article Neurosciences

Regulatory function of microRNAs in microglia

Dora Brites

Review Clinical Neurology

The Regulation of microRNAs in Alzheimer's Disease

Xianjuan Kou et al.

FRONTIERS IN NEUROLOGY (2020)

Review Medicine, Research & Experimental

The Promising Role of miR-21 as a Cancer Biomarker and Its Importance in RNA-Based Therapeutics

Diana Bautista-Sanchez et al.

MOLECULAR THERAPY-NUCLEIC ACIDS (2020)

Review Health Care Sciences & Services

Current Biomarkers for Alzheimer's Disease: From CSF to Blood

Kun Zou et al.

JOURNAL OF PERSONALIZED MEDICINE (2020)

Review Neurosciences

MicroRNAs in Alzheimer's Disease: Function and Potential Applications as Diagnostic Biomarkers

Wei Wei et al.

FRONTIERS IN MOLECULAR NEUROSCIENCE (2020)

Review Cell & Tissue Engineering

iPSC for modeling neurodegenerative disorders

Valeria Valadez-Barba et al.

REGENERATIVE THERAPY (2020)

Article Clinical Neurology

The protective effect of microRNA-21 in neurons after spinal cord injury

Tao Zhang et al.

SPINAL CORD (2019)

Review Neurosciences

Alzheimer's in a dish - induced pluripotent stem cell-based disease modeling

Sherida de Leeuw et al.

TRANSLATIONAL NEURODEGENERATION (2019)

Article Cell & Tissue Engineering

PSEN1ΔE9, APPswe, and APOE4 Confer Disparate Phenotypes in Human iPSC-Derived Microglia

Henna Konttinen et al.

STEM CELL REPORTS (2019)

Letter Medicine, General & Internal

Unsuccessful trials of therapies for Alzheimer's disease

Jonathan M. Schott et al.

LANCET (2019)

Review Biochemistry & Molecular Biology

Astrocyte Biomarkers in Alzheimer's Disease

Stephen F. Carter et al.

TRENDS IN MOLECULAR MEDICINE (2019)

Article Multidisciplinary Sciences

miR-124 dosage regulates prefrontal cortex function by dopaminergic modulation

Takashi Kozuka et al.

SCIENTIFIC REPORTS (2019)

Review Cell Biology

Microglia in Alzheimer's disease

David V. Hansen et al.

JOURNAL OF CELL BIOLOGY (2018)

Article Medicine, Research & Experimental

MiR-21 attenuates apoptosis-triggered by amyloid-β via modulating PDCD4/ PI3K/AKT/GSK-3β pathway in SH-SY5Y cells

Mei-Guo Feng et al.

BIOMEDICINE & PHARMACOTHERAPY (2018)

Article Biochemistry & Molecular Biology

Knockdown of MicroRNA-21 Promotes Neurological Recovery After Acute Spinal Cord Injury

Wei Xie et al.

NEUROCHEMICAL RESEARCH (2018)

Review Geriatrics & Gerontology

Deciphering the Astrocyte Reaction in Alzheimer's Disease

Beatriz G. Perez-Nievas et al.

FRONTIERS IN AGING NEUROSCIENCE (2018)

Article Cell & Tissue Engineering

Functional Studies of Missense TREM2 Mutations in Human Stem Cell-Derived Microglia

Philip W. Brownjohn et al.

STEM CELL REPORTS (2018)

Article Neurosciences

Dysregulation of Astrocytic HMGB1 Signaling in Amyotrophic Lateral Sclerosis

Liliana Brambilla et al.

FRONTIERS IN NEUROSCIENCE (2018)

Article Microbiology

Microglia Increase Inflammatory Responses in iPSC-Derived Human BrainSpheres

Celina Monteiro Abreu et al.

FRONTIERS IN MICROBIOLOGY (2018)

Review Clinical Neurology

Alzheimer's disease: experimental models and reality

Eleanor Drummond et al.

ACTA NEUROPATHOLOGICA (2017)

Review Neurosciences

Astrocyte Dysfunction in Alzheimer Disease

Crystal Acosta et al.

JOURNAL OF NEUROSCIENCE RESEARCH (2017)

Review Neurosciences

The SH-SY5Y cell line in Parkinson's disease research: a systematic review

Helena Xicoy et al.

MOLECULAR NEURODEGENERATION (2017)

Article Multidisciplinary Sciences

Neurotoxic reactive astrocytes are induced by activated microglia

Shane A. Liddelow et al.

NATURE (2017)

Article Multidisciplinary Sciences

Defective synaptic connectivity and axonal neuropathology in a human iPSC-based model of familial Parkinson's disease

Georgia Kouroupi et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)

Article Neurosciences

Differentiation of Human Induced Pluripotent Stem Cell (hiPSC)-Derived Neurons in Mouse Hippocampal Slice Cultures

Toshimitsu Hiragi et al.

FRONTIERS IN CELLULAR NEUROSCIENCE (2017)

Article Cell Biology

Aberrant iPSC-derived human astrocytes in Alzheimer's disease

V. C. Jones et al.

CELL DEATH & DISEASE (2017)

Review Neurosciences

Involvement of Astrocytes in Alzheimer's Disease from a Neuroinflammatory and Oxidative Stress Perspective

Rodrigo E. Gonzalez-Reyes et al.

FRONTIERS IN MOLECULAR NEUROSCIENCE (2017)

Article Cell & Tissue Engineering

PSEN1 Mutant iPSC-Derived Model Reveals Severe Astrocyte Pathology in Alzheimer's Disease

Minna Oksanen et al.

STEM CELL REPORTS (2017)

Review Neurosciences

Back and forth in time: Directing age in iPSC-derived lineages

Daniela Cornacchia et al.

BRAIN RESEARCH (2017)

Review Biochemistry & Molecular Biology

The contribution of neuroinflammation to amyloid toxicity in Alzheimer's disease

Myles R. Minter et al.

JOURNAL OF NEUROCHEMISTRY (2016)

Review Biochemistry & Molecular Biology

The Cellular Phase of Alzheimer's Disease

Bart De Strooper et al.

Article Biochemistry & Molecular Biology

Efficient derivation of microglia-like cells from human pluripotent stem cells

Julien Muffat et al.

NATURE MEDICINE (2016)

Review Cell & Tissue Engineering

Modeling Alzheimer's Disease with Induced Pluripotent Stem Cells: Current Challenges and Future Concerns

Weiwei Zhang et al.

STEM CELLS INTERNATIONAL (2016)

Article Immunology

Arginase 1+microglia reduce Aβ plaque deposition during IL-1β-dependent neuroinflammation

Jonathan D. Cherry et al.

JOURNAL OF NEUROINFLAMMATION (2015)

Review Clinical Neurology

Neuroinflammation in Alzheimer's disease

Michael T. Heneka et al.

LANCET NEUROLOGY (2015)

Review Immunology

Turning 21: induction of miR-21 as a key swith in the inflammatory response

Frederick J. Sheedy

FRONTIERS IN IMMUNOLOGY (2015)

Article Medical Laboratory Technology

Biobanking of CSF: International standardization to optimize biomarker development

Charlotte E. Teunissen et al.

CLINICAL BIOCHEMISTRY (2014)

Article Neurosciences

Cross-Talk Between Neurons and Astrocytes in Response to Bilirubin: Adverse Secondary Impacts

Ana Sofia Falcao et al.

NEUROTOXICITY RESEARCH (2014)

Article Neurosciences

Microglia change from a reactive to an age-like phenotype with the time in culture

Claudia Caldeira et al.

FRONTIERS IN CELLULAR NEUROSCIENCE (2014)

Article Multidisciplinary Sciences

Essential Role of MFG-E8 for Phagocytic Properties of Microglial Cells

Yong Liu et al.

PLOS ONE (2013)

Article Neurosciences

microRNA-21 Regulates Astrocytic Response Following Spinal Cord Injury

Oneil G. Bhalala et al.

JOURNAL OF NEUROSCIENCE (2012)

Article Multidisciplinary Sciences

Probing sporadic and familial Alzheimer's disease using induced pluripotent stem cells

Mason A. Israel et al.

NATURE (2012)

Article Biochemical Research Methods

Fiji: an open-source platform for biological-image analysis

Johannes Schindelin et al.

NATURE METHODS (2012)

Article Biochemical Research Methods

Directed differentiation of functional astroglial subtypes from human pluripotent stem cells

Robert Krencik et al.

NATURE PROTOCOLS (2011)

Article Neurosciences

Neuropathologic Alterations in Mild Cognitive Impairment: A Review

William R. Markesbery

JOURNAL OF ALZHEIMERS DISEASE (2010)

Article Multidisciplinary Sciences

Neuronal MicroRNA Deregulation in Response to Alzheimer's Disease Amyloid-β

Nicole Schonrock et al.

PLOS ONE (2010)

Article Biotechnology & Applied Microbiology

Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling

Stuart M. Chambers et al.

NATURE BIOTECHNOLOGY (2009)

Article Biochemistry & Molecular Biology

PPARα ligands inhibit radiation-induced microglial inflammatory responses by negatively regulating NF-κB and AP-1 pathways

Sriram Ramanan et al.

FREE RADICAL BIOLOGY AND MEDICINE (2008)

Article Neurosciences

MFG-E8 Regulates Microglial Phagocytosis of Apoptotic Neurons

Abby D. Fuller et al.

JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2008)

Article Neurosciences

Microglial dysfunction and defective β-amyloid clearance pathways in aging Alzheimer's disease mice

Suzanne E. Hickman et al.

JOURNAL OF NEUROSCIENCE (2008)